U.S. flag

An official website of the United States government

GTR Home > Genes

ABHD12 abhydrolase domain containing 12, lysophospholipase

Gene ID: 26090, updated on 14-Nov-2024
Gene type: protein coding
Also known as: PHARC; ABHD12A; BEM46L2; hABHD12; C20orf22; dJ965G21.2

Summary

This gene encodes an enzyme that catalyzes the hydrolysis of 2-arachidonoyl glycerol (2-AG), the main endocannabinoid lipid transmitter that acts on cannabinoid receptors, CB1 and CB2. The endocannabinoid system is involved in a wide range of physiological processes, including neurotransmission, mood, appetite, pain appreciation, addiction behavior, and inflammation. Mutations in this gene are associated with the neurodegenerative disease, PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract), resulting from an inborn error of endocannabinoid metabolism. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Jan 2011]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.
GeneReviews: Not available
PHARC syndrome
MedGen: C2675204OMIM: 612674GeneReviews: Not available
See labs

Genomic context

Location:
20p11.21
Sequence:
Chromosome: 20; NC_000020.11 (25294743..25390835, complement)
Total number of exons:
18

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.